Amanda Luz Henning Santiago reports for City and State that there is talk in New York about legalizing other drugs besides cannabis. Some state lawmakers have introduced legislation to decriminalize psilocybin and psilocyn, and to decriminalize the possession of all controlled substances. Nationally, the Food and Drug Administration has already given psychedelics psilocybin and MDMA “breakthrough therapy status.” That has helped free up both New York University and Mount Sinai's psychedelic research programs. “Psychedelic substances, by far and large, are relatively safe substances, especially when compared to what the government believes their level of safety is,” said Troy Smit, deputy director of the Empire State National Organization for the Reform of Marijuana Laws. “What I'm saying is that there is a big discrepancy between a psychedelic substance’s schedule one status and what the actual research and science shows about those drugs.” While New York lawmakers made cannabis legal this year, State Sen. Gustavo Rivera's bills in Albany to decriminalize other drugs probably won't reach a vote until at least 2022. Read more about this story in City and State.